Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | EMR | Common Stock | Award | +18.5K | +6.97% | 284K | Nov 4, 2024 | Direct | F1, F2 | ||
transaction | EMR | Common Stock | Tax liability | -$891K | -8.16K | -2.88% | $109.11 | 276K | Nov 4, 2024 | Direct | F3, F4 |
transaction | EMR | Common Stock | Award | +8.19K | +2.97% | 284K | Nov 4, 2024 | Direct | F5, F6 | ||
holding | EMR | Common Stock | 845 | Nov 4, 2024 | Profit Sharing Plan | ||||||
holding | EMR | Common Stock | 11.5K | Nov 4, 2024 | 401(k) plan | ||||||
holding | EMR | Common Stock | 1.35K | Nov 4, 2024 | 401(k) excess plan |
Id | Content |
---|---|
F1 | Acquisition of shares pursuant to Rule 16b-3 upon payout of 18,488 earned units under a performance share award under a shareholder-approved benefit plan. The payout was based on the level of achievement of financial targets for the performance period ended September 30, 2024. |
F2 | Price is not applicable to the acquisition described in Note 1. |
F3 | Shares withheld for required minimum taxes upon vesting of units under a performance share award described in Note 1. |
F4 | Fair market value on date of withholding described in Note 1. |
F5 | Grant to Reporting Person of 8,192 restricted stock units under shareholder approved benefit plan pursuant to Rule 16b-3(d). |
F6 | Price is not applicable to acquisitions resulting from grants of restricted stock units. |